Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression.

These data clearly suggested a reduced tumor growth in mice bearing shPI3K-C2β MDA-MB-231 cells compared to mice injected with control cells, although differences did not reach statistical significance possibly because of high variability of tumors volume (Figure 1F ).

also in 111,027 other papers